A examine volunteer receiving Intellia’s transthyretin amyloidosis remedy was hospitalized as a consequence of extreme indicators of liver stress, prompting the corporate to pause enrollment and dosing whereas evaluating a brand new security protocol.
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the most recent breakthroughs, get unique updates, and join with a world community of future-focused thinkers.
Unlock tomorrow’s traits as we speak: learn extra, subscribe to our e-newsletter, and grow to be a part of the NextTech group at NextTech-news.com
